
Laricef 1gm/500mg Injection
Marketer
Larion Life Sciences Pvt Ltd
Salt Composition
Cefoperazone (1gm) + Sulbactam (500mg)
Overview Laricef 1gm/500mg Injection
Cefixime and Sulbactam injection (1g/500mg) is a dual-action antibiotic. This medication combats various bacterial infections by inhibiting microbial growth and halting infection spread. Administration must be strictly under a doctor's guidance. Complete the prescribed dosage regimen; premature cessation can reduce its effectiveness. Regularly scheduled doses are crucial. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, itching, swelling, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals require a doctor's consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration promote faster recovery. Your doctor may order lab tests to monitor treatment response.
Uses of Laricef 1gm/500mg Injection
Managing bacterial illnesses
Major Benefits of Laricef 1gm/500mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Laricef 1gm/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Laricef 1gm/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Laricef 1gm/500mg Injection works:
Laricef, a 1 gram/500 milligram injectable formulation, unites the antibacterial actions of Cefoperazone and Sulbactam. Cefoperazone, an antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby augmenting Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
The concurrent use of Laricef 1gm/500mg Injection and alcohol can result in adverse effects including facial flushing, tachycardia, nausea, thirst, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable formulation of Laricef (1g/500mg) is typically regarded as safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; however, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
During breastfeeding, administration of Laricef 1gm/500mg Injection presents a low risk. Research in humans indicates minimal drug transfer to breast milk, posing no substantial threat to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Laricef 1gm/500mg Injection on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Laricef 1gm/500mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Laricef 1gm/500mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Laricef 1gm/500mg Injection :
Should you forget a scheduled dose of Laricef 1gm/500mg Injection, seek medical advice.
Facts to Know About Laricef 1gm/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
